Proteasomal non‐catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomasYasushi Matsuyama, Takashi Takahashi, Chinatsu Arima et al.|Molecular Carcinogenesis|2011Cited by 72